Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC‐MS/MS, Docking, MD Simulations, and In Vitro Evaluation
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202501930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Dharipally Harini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Breast Neoplasms, Antineoplastic Agents, Phytogenic, Phytochemicals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Breast cancer remains one of the leading causes of cancer‐related mortality in women, emphasizing the urgent need for safer and more effective therapeutic agents. Natural phytochemicals, due to their structural diversity and pharmacological potential, are increasingly recognized as promising candidates in anticancer research. In this study, the anticancer activity of the n‐hexane extract from Gmelina arborea leaves was evaluated through a multidisciplinary approach involving LC‐MS/MS analysis, molecular docking, molecular dynamics (MD) simulation, and in vitro cytotoxicity assays. LC‐MS/MS profiling identified 83 phytochemicals based on accurate mass measurements and fragmentation patterns. Among them, hesperetin‐3′,5,7‐tri‐glucuronide, emerged as a key compound due to its potential interaction with the epidermal growth factor receptor (EGFR). Molecular docking studies using EGFR crystal structures (1M17 and 1IVO) revealed strong binding affinities of –9.122 and −7.246 kJ/mol, respectively. MD simulations further validated the complex stability for compound 77. Additionally, the extract demonstrated cytotoxic activity against MCF‐7, HepG2, and HEK‐293 cell lines, with the strongest activity observed in MCF‐7 breast cancer cells. These findings were further supported with a clonogenic assay on MCF‐7 cells using IC 50 concentration. Overall, the findings highlight Gmelina arborea as a promising source of anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, India.
- Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, India.
- Department of Dravyaguna, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
ORCID-Profile: Gananadhamu Samanthula
Zitieren
APA
Harini, D., Mouli, H. M. C., Raman, P. K., Singh, N., Shreya, S., Khemchandani, R., Shaikh, N., Godugu, C., & Samanthula, G. (2026). Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC‐MS/MS, Docking, MD Simulations, and In Vitro Evaluation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501930
Vancouver
Harini D, Mouli HMC, Raman PK, Singh N, Shreya S, Khemchandani R, et al. Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC‐MS/MS, Docking, MD Simulations, and In Vitro Evaluation. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202501930
BibTeX
@article{Harini2026,
author = {Harini, Dharipally and Mouli, H M Chandra and Raman, Preethi K and Singh, Nivedita and Shreya, Shambhavi and Khemchandani, Rahul and Shaikh, Nadeem and Godugu, Chandraiah and Samanthula, Gananadhamu},
title = {Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC‐MS/MS, Docking, MD Simulations, and In Vitro Evaluation},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202501930}
}
EUVIMED